Basit öğe kaydını göster

dc.contributor.authorBora-Tatar, Gamze
dc.contributor.authorErdem-Yurter, Hayat
dc.date.accessioned2019-12-12T06:25:07Z
dc.date.available2019-12-12T06:25:07Z
dc.date.issued2014
dc.identifier.issn2314-6133
dc.identifier.urihttps://doi.org/10.1155/2014/709108
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101952/
dc.identifier.urihttp://hdl.handle.net/11655/16251
dc.description.abstractSpinal Muscular Atrophy (SMA) is an autosomal recessive neurodegenerative disease with progressive muscle weakness and atrophy. SMA is caused by low levels of the Survival of Motor Neuron (SMN) protein, which also leads to neurite outgrowth defects in neuronal cells. Rescue of the outgrowth defect is thought to be a strategy for SMA treatment. Polyphenolic histone deacetylase (HDAC) inhibitors might be good candidates due to their neuritogenic properties. In the present study, it was investigated whether neurite outgrowth defects could be rescued by curcumin and resveratrol, which are SMN-inducing polyphenols, having HDAC inhibition activity. According to our results, although curcumin and resveratrol failed to restore the neurite outgrowth defects, the SMN protein was found to be necessary for the neurite-promoting activity of curcumin in neuron-like PC12 cells.
dc.language.isoen
dc.relation.isversionof10.1155/2014/709108
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleInvestigations of Curcumin and Resveratrol on Neurite Outgrowth: Perspectives on Spinal Muscular Atrophy
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalBioMed Research International
dc.contributor.departmentTıbbi Biyoloji
dc.identifier.volume2014
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster